HomeLife SpinePROLIFT® Lateral Fixated System Receives FDA Clearance

PROLIFT® Lateral Fixated System Receives FDA Clearance

Today Life Spine announced they have received clearance from the U.S. Food & Drug Administration (FDA) to market the PROLIFT Lateral Fixated System.

PROLIFT Lateral Fixated System combines the innovation of the SENTRY® Lateral Plate with the technology of the Lateral PROLIFT Expandable System for a simplified Lateral procedure,” said Mariusz Knap, Sr. Vice President of Sales and Marketing for Life Spine. “The system has integrated fixation and cam locks which offer visual, tactile and audible confirmation of final locking. Additionally, PROLIFT Lateral Fixated can be post packed in situ through the inserter and offers an extensive range of footprints. This system is a key addition to our rapidly growing Expandable portfolio.”

PROLIFT Lateral Fixated comes in widths of 18mm and 22mm, heights ranging from 8mm to 19mm, three lordotic options and lengths of 40mm to 60mm in 5mm increments. It is complemented by Life Spine’s full Lateral portfolio including the CENTRIC® Plier Style Retractor and Lateral Disc Prep.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

Skyhawk Therapeutics Completes New Investment Round

A $133 million round of investment will allow Skyhawk to accelerate development of its novel small molecule RNA-modifying drug candidates into the clinic.

By using this website you agree to accept Medical Device News Magazine Privacy Policy